WHO Supplementary Guideline for the manufacture of investigational pharmaceutical products for clinical trials in humans

Titel:
WHO Supplementary Guideline for the manufacture of investigational pharmaceutical products for clinical trials in humans
Herkunft/Verlag:

WHO headquarters, Avenue Appia 20, 1211 Geneva 27, Switzerland Telephone: (+ 41 22) 791 21 11, Facsimile (fax): (+ 41 22) 791 3111, Telex: 415 416, Telegraph: UNISANTE GENEVA

Inhalt:
GMP für die Herstellung von Produkten für klinische Studien

Zurück

GMP Seminare nach Thema